TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
RGEN

Repligen Corporation

Healthcare · Medical Instruments & Supplies

176.90$ -0.7% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

Repligen Corporation (RGEN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at 33 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow RGEN
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
39 29 45 42 49 39 15 29 48 26 28 33 135
20 25 21 17 21 35 23 25 24 25 25 14 88
6.4 6.5 8.8 9.2 23 6.4 7.3 8.4 9.0 8.0 8.3 8.0 33
37 -12 8.6 11 2.0 34 -26 -12 12 -24 -22 -5.9 -40
9.0 11 8.4 7.4 7.1 7.0 4.4 7.6 5.4 8.7 4.9 5.1 24
-8.8 -170 -8.4 -5.9 -65 -74 -7.8 -7.8 -209 -4.0 -2.1 -223
0.3 0.3
0.0 -14 -7.6 -1.2 -1.2 -0.5 -6.5 -0.7 7.2 -14 -5.5 -1.1 -13
0.0 0.0
-0.8 268 -9.0 -5.8 -70 1.4 -5.0 -10 -0.2 0.2 -5.5 -6.2 -12
27 121 29 29 -25 -27 -60 12 40 -183 17 24 -102
30 18 36 35 42 32 11 21 43 17 23 28 111

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?